Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
D000085:Acetates / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D006801:Humans; D007223:Infant; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D034721:Mastocytosis, Systemic / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides
D000085:Acetates; D000893:Anti-Inflammatory Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast; D011241:Prednisone